OTC Markets Group Inc. (OTCQX:OTCM) announced that Vaxart, Inc. (OTCQX: VXRT), a clinical-stage biotech firm developing oral vaccines, has qualified to trade on the OTCQX Best Market after previously trading on NASDAQ.
Vaxart begins trading today under the symbol “VXRT.”
CEO Steven Lo thanked investors and said the company remains committed to advancing its oral vaccine technology.
The OTCQX market offers efficient U.S. capital access with streamlined requirements and transparency for investors.